UpDoc just landed the first FDA clearance ever for a medical device built on patient-facing LLMs, with an AI that manages a Type 2 diabetic's insulin between doctor visits. What it's cleared to do, within the parameters a physician sets first: - Call or message the patient - Change the insulin dose off glucose-monitor readings or what the patient reports - Order follow-up tests - Log every decision in the patient's medical record It followed a clinical trial the founders (both physicians) ran at Stanford Medicine. UpDoc CEO Sharif Vakili: "It's like I've deployed a concierge doctor to follow up with the patient." AI is bringing some much needed acceleration to a slow, reactive healthcare system Video
This AimostAll brief summarizes the linked source so readers can scan AI developments quickly and jump to the original reporting when needed.